Wenhui Li Selected Research

sodium-bile acid cotransporter

10/2021	Entry of hepatitis B virus: going beyond NTCP to the nucleus.
1/2018	Silencing Retinoid X Receptor Alpha Expression Enhances Early-Stage Hepatitis B Virus Infection In Cell Cultures.
1/2018	The p.Ser267Phe variant of sodium taurocholate cotransporting polypeptide (NTCP) supports HBV infection with a low efficiency.
1/2017	Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
10/2016	DNA Polymerase κ Is a Key Cellular Factor for the Formation of Covalently Closed Circular DNA of Hepatitis B Virus.
10/2016	Modification of Three Amino Acids in Sodium Taurocholate Cotransporting Polypeptide Renders Mice Susceptible to Infection with Hepatitis D Virus In Vivo.
1/2015	Sodium taurocholate cotransporting polypeptide acts as a receptor for hepatitis B and D virus.
3/2014	Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
2/2014	NTCP and beyond: opening the door to unveil hepatitis B virus entry.
1/2014	microRNA expression in hepatitis B virus infected primary treeshrew hepatocytes and the independence of intracellular miR-122 level for de novo HBV infection in culture.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenhui Li Research Topics

Disease

47	Infections 01/2022 - 07/2003
37	Neoplasms (Cancer) 12/2022 - 04/2002
14	Virus Diseases (Viral Diseases) 01/2020 - 02/2012
12	Type 2 Diabetes Mellitus (MODY) 01/2022 - 03/2008
10	Breast Neoplasms (Breast Cancer) 03/2022 - 11/2016
10	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2016
9	Stomach Neoplasms (Stomach Cancer) 06/2021 - 10/2011
9	Hepatitis B 01/2018 - 11/2012
8	Severe Acute Respiratory Syndrome 05/2006 - 11/2003
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2010
6	Carcinoma (Carcinomatosis) 06/2021 - 04/2002
5	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2016
5	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 09/2013
4	Hypoglycemia (Reactive Hypoglycemia) 01/2022 - 11/2015
4	Inflammation (Inflammations) 01/2020 - 03/2016
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 11/2016
3	Seizures (Absence Seizure) 05/2022 - 01/2019
3	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 08/2012
3	COVID-19 11/2021 - 12/2020
3	Mitochondrial Diseases (Mitochondrial Disease) 10/2021 - 01/2019
3	Lymphatic Metastasis 06/2021 - 10/2014
3	Nasopharyngeal Carcinoma 01/2021 - 10/2014
3	Myasthenia Gravis 12/2020 - 11/2017
3	Chronic Hepatitis B 01/2020 - 09/2017
3	Weight Loss (Weight Reduction) 01/2019 - 07/2017
2	Epilepsy (Aura) 05/2022 - 07/2020
2	Venous Thrombosis (Deep-Vein Thrombosis) 11/2021 - 01/2021
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2021 - 07/2021
2	Rheumatoid Arthritis 07/2021 - 11/2013
2	Triple Negative Breast Neoplasms 01/2021 - 10/2018
2	Obesity 01/2021 - 01/2017
2	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2021 - 01/2020
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2013
2	Severe Fever with Thrombocytopenia Syndrome 01/2019 - 01/2014
2	Adenocarcinoma of Lung 09/2018 - 12/2016
2	Carcinogenesis 08/2018 - 08/2016
2	Colorectal Neoplasms (Colorectal Cancer) 04/2018 - 01/2017
2	Hyperglycemia 04/2017 - 01/2017
2	Insulin Resistance 01/2017 - 01/2011
2	Colonic Neoplasms (Colon Cancer) 10/2016 - 10/2008

Drug/Important Bio-Agent (IBA)

36	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2002
16	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2004
14	sodium-bile acid cotransporterIBA 10/2021 - 11/2012
10	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 03/2008
9	VaccinesIBA 11/2021 - 06/2006
8	Pharmaceutical PreparationsIBA 04/2022 - 03/2014
7	Biomarkers (Surrogate Marker)IBA 04/2022 - 11/2016
7	Biological ProductsIBA 03/2022 - 01/2018
7	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2013
7	EnzymesIBA 07/2021 - 10/2004
7	Peptides (Polypeptides)IBA 01/2021 - 06/2013
6	AntibodiesIBA 12/2020 - 11/2004
5	Long Noncoding RNAIBA 01/2022 - 12/2016
5	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
5	AntigensIBA 11/2021 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 06/2016
5	Small Interfering RNA (siRNA)IBA 01/2021 - 01/2014
5	Messenger RNA (mRNA)IBA 01/2020 - 10/2011
5	Taurocholic Acid (Sodium Taurocholate)IBA 01/2018 - 07/2013
5	Glycoproteins (Glycoprotein)IBA 07/2015 - 07/2003
4	CytokinesIBA 01/2022 - 09/2013
4	Neutralizing AntibodiesIBA 12/2020 - 01/2004
4	Amino Acids FDA Link 10/2016 - 11/2012
3	LigandsIBA 01/2021 - 10/2008
3	Estrogen ReceptorsIBA 01/2021 - 06/2014
3	Histones (Histone)IBA 01/2021 - 08/2018
3	Bile Acids and Salts (Bile Acids)IBA 05/2020 - 03/2014
3	VimentinIBA 03/2019 - 10/2016
3	Cadherins (E-Cadherin)IBA 01/2017 - 10/2016
3	Insulin (Novolin)FDA Link 01/2017 - 03/2008
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 11/2015 - 04/2002
2	Transcription Factors (Transcription Factor)IBA 03/2022 - 01/2018
2	DorzagliatinIBA 01/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 01/2018
2	Prednisone (Sone)FDA LinkGeneric 10/2021 - 01/2019
2	Exenatide (Byetta)FDA Link 08/2021 - 01/2021
2	ImmunosorbentsIBA 07/2021 - 01/2019
2	Subunit VaccinesIBA 03/2021 - 01/2017
2	Panax notoginseng extractIBA 01/2021 - 01/2013
2	Phosphotransferases (Kinase)IBA 01/2021 - 01/2019
2	Protein Kinases (Protein Kinase)IBA 01/2021 - 01/2019
2	AcidsIBA 01/2021 - 08/2018
2	Lysine (L-Lysine)FDA Link 01/2021 - 10/2016
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2021 - 08/2018
2	Cholinergic ReceptorsIBA 12/2020 - 01/2019
2	Tamoxifen FDA LinkGeneric 01/2020 - 10/2017
2	CarcinogensIBA 01/2019 - 01/2016
2	Circular DNAIBA 01/2019 - 01/2018
2	sanyang xuedaiIBA 06/2018 - 01/2018
2	alogliptinIBA 04/2017 - 11/2015
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 09/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 10/2011
2	resolvin D1IBA 10/2016 - 03/2016

Therapy/Procedure

21	Therapeutics 12/2022 - 02/2004
13	Radiotherapy 01/2021 - 10/2014
6	Immunotherapy 01/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 01/2022 - 10/2011
3	Chemoradiotherapy 12/2020 - 06/2010
2	Precision Medicine 05/2022 - 01/2021
2	Induction Chemotherapy 12/2020 - 01/2020